November 18, 2022 11:18 AM EST
News Briefing

PaxMed­ica surges af­ter fi­nanc­ing; Mar­i­nus makes Chi­na de­vel­op­ment and sales pact

Drew Armstrong

Executive Editor

Shares of small-cap drug­mak­er PaxMed­ica surged 65% on Fri­day af­ter the com­pa­ny an­nounced a fi­nanc­ing deal worth as much as $20 mil­lion with the in­vest­ment …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Ky­owa Kirin ac­quires ex-US rights to Ku­ra’s leukemia treat­ment for $330M up­front

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times